Literature DB >> 21241994

Peripherin partially localizes in Bunina bodies in amyotrophic lateral sclerosis.

Yuji Mizuno1, Yukio Fujita, Masamitsu Takatama, Koichi Okamoto.   

Abstract

Peripherin is a type III intermediate filament protein expressed with low levels in spinal motor neurons. Amyotrophic lateral sclerosis (ALS) is characterized by the presence of Bunina bodies, skein-like inclusions, and Lewy body-like inclusions (LBLIs) in the remaining anterior horn cells, where the first and third structures are detected by Hematoxylin-Eosin (H & E) staining. We examined paraffin sections of lumbar spinal cords from six ALS patients, using H & E staining and immunostaining for human peripherin. The results demonstrated that there were a total of 73 anterior horn cells containing one or more Bunina bodies, and that twelve of these cells (approximately 16.4%) demonstrated peripherin-positive Bunina bodies. In fact, some part of chain-like Bunina bodies showed peripherin-positive reaction, although there were a much higher number of non-immunoreacitive Bunina bodies in each neuron. LBLIs were clearly immunostained for peripherin corresponding to the core, while some of them showed different types of immunoreactivities due to oblique cutting of inclusions. Our findings suggest that although the mechanisms underlying peripherin co-localization in Bunina bodies are unknown, peripherin could be involved in forming these inclusions. Furthermore, following cystatin C and transferrin, peripherin is the third most prevalent protein that partially localizes in Bunina bodies.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241994     DOI: 10.1016/j.jns.2010.12.023

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

Review 2.  TDP-43 and Cytoskeletal Proteins in ALS.

Authors:  Moritz Oberstadt; Joseph Claßen; Thomas Arendt; Max Holzer
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

3.  Identification of 17 Highly Expressed Genes within Mouse Lumbar Spinal Cord Anterior Horn Region from an In-Situ Hybridization Atlas of 3430 Genes: Implications for Motor Neuron Disease.

Authors:  Michael A Meyer
Journal:  Neurol Int       Date:  2014-06-16

Review 4.  Disrupted neuronal trafficking in amyotrophic lateral sclerosis.

Authors:  Katja Burk; R Jeroen Pasterkamp
Journal:  Acta Neuropathol       Date:  2019-02-05       Impact factor: 17.088

5.  Does conserved domain SOD1 mutation has any role in ALS severity and therapeutic outcome?

Authors:  Surinder Pal; Abha Tiwari; Kaushal Sharma; Suresh Kumar Sharma
Journal:  BMC Neurosci       Date:  2020-10-09       Impact factor: 3.288

Review 6.  Genetics of amyotrophic lateral sclerosis: an update.

Authors:  Sheng Chen; Pavani Sayana; Xiaojie Zhang; Weidong Le
Journal:  Mol Neurodegener       Date:  2013-08-13       Impact factor: 14.195

Review 7.  Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?

Authors:  Christopher P Webster; Emma F Smith; Pamela J Shaw; Kurt J De Vos
Journal:  Front Mol Neurosci       Date:  2017-05-02       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.